New induction of leukotriene A4 hydrolase by interleukin-4 and interleukin-13 in human polymorphonuclear leukocytes

Blood

Volumn 96, Issue 2, 2000, Pages 601-609

  Zaitsu, Masafumi ^a   Hamasaki, Yuhei ^a   Matsuo, Muneaki ^a   Kukita, Akiko ^a   Tsuji, Kosuke ^a   Miyazaki, Michiko ^a   Hayasaki, Rika ^a   Muro, Eriko ^a   Yamamoto, Shuichi ^a   Kobayashi, Ikuko ^a   Ichimaru, Tomohiro ^a   Kohashi, Osamu ^a   Miyazaki, Sumio ^a  

^a SAGA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; LEUKOTRIENE A4 HYDROLASE; LEUKOTRIENE B4; THROMBOXANE B2;

ARTICLE; ENZYME INDUCTION; HUMAN; HUMAN CELL; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS;

EID: 18344412674     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.2.601     Document Type: Article

References (68)

1. Kay AB. Th2-type cytokines in asthma. Ann N Y Acad Sci. 1996;796:1-6.
2. Shi HZ, Qin SM, Huang GW, et al. Infiltration of eosinophils into the asthmatic airways caused by interleukin-5. Am J Respir Cell Mol Biol. 1997;16: 220-224.
3. Zangrilli JG, Sharer JR, Cirelli RA, et al. sV-CAM-1 levels after segmental antigen challenge correlate with eosinophil influx, IL-4 and IL-5 production, and the late phase response. Am J Respir Crit Care Med. 1995;151:1346-1353.
4. Fukuda T, Fukushima Y, Numao T, et al. Role of interleukin-4 and vascular cell adhesion molecule-1 in selective eosinophil migration into the airway in allergic asthma. Am J Respir Cell Mol Biol. 1995;14:34-94.
5. Shi HZ, Deng JM, Xu H, et al. Effect of inhaled interleukin-4 on airway hyperreactivity in asthmatics. Am J Respir Crit Care Med. 1998;157:1818-1821.
6. Shi HZ, Xiao CQ, Zhong O, et al. Effect of inhaled interleukin-5 on airway hyperreactivity and eosinophilia in asthmatics. Am J Respir Crit Care Med. 1998;157:204-209.
7. Smith HR, Larsen GL, Cherniack RM, et al. Inflammatory cells and eicosanoid mediators in subjects with late asthmatic responses and increases in airway responsiveness. J Allergy Clin Immunol. 1992;89:1076-1084.
8. Wenzel SE, Westcott JY, Larsen GL. Bronchoalveolar lavage fluid mediator levels 5 minutes after allergen challenge in atopic subjects with asthmarelationship to the development of late asthmatic responses. J Allergy Clin Immunol. 1991;87:540-548.
9. Wenzel SE. Abnormalities of cell and mediator levels in bronchoalveolar lavage fluid of patients with mild asthma. J Allergy Clin Immunol. 1996; 98:S17-S21.
10. 2 and prostaglandin endoperoxide synthase 2 and their roles in separate pathways of eicosanoid synthesis in mouse bone marrow-derived mast cells. Proc Natl Acad Sci USA. 1995;92:6107-6111.
11. 4 synthase pathway in mouse mast cells. J Biol Chem. 1995;270:22653-22656.
12. Hempel SL, Monick MM, Hunninghake GW. Lipopotysaccharide induces prostaglandin H synthase-2 protein and mRNA in human alveolar macrophages and blood monocytes. J Clin Invest. 1994;93:391-396.
13. Riddick CA, Ring WL, Baker JR, Hodulik CR, Bigby TD. Dexamethasone increases expression of 5-lipoxygenase and its activating protein in human monocytes and THP-1 cells. Eur J Biochem. 1997;246:112-118.
14. Stankova J, Rola-Pleszczynski M, Dubois CM. Granulocyte-macrophage colony-stimulating factor increases 5-lipoxygenase gene transcription and protein expression in human neutrophils. Blood. 1995;85:3719-3726.
15. Pouliot M, McDonald PP, Khamzina L, Borgeat P, McColl SR. Granulocyte-macrophage colony-stimulating factor enhances 5-lipoxygenase level in human polymorphonuclear leukocytes. J Immunol. 1994;152:851-858.
16. O'Banion MK, Miller JC, Chang JW, Kaplan MD, Coleman PD. Interleukin-1 beta induces prostaglandin G/H synthase-2 (cyclooxygenase-2) in primary murine astrocyte cultures. J Neurochem. 1996;66:2532-2540.
17. Hamasaki Y, Kitzler J, Hardman R, Nettesheim P, Eling TE. Phorbol ester and epidermal growth factor enhance the expression of two inducible prostaglandin H synthase genes in rat tracheal epithelial cells. Arch Biochem Biophys. 1993;304: 226-234.
18. Zaitsu M, Hamasaki Y, Yamamoto S, et al. Effect of dexamethasone on leukotriene synthesis in DMSO-stimulated HL-60 cells. Prostaglandins Leukot Essent Fatty Acids. 1998;59:385-393.
19. Scoggan KA, Nicholson DW, Ford-Hutchinson WF. Regulation of leukotriene-biosynthetic enzymes during differentiation of myelocytic HL-60 cells to eosinophilic or neutrophilic cells. Eur J Biochem. 1996;239:572-578.
20. 2 synthase-2 by lipopolysaccharide in human polymorphonuclear leukocytes. Eur J Haematol. 1999;63:94-102.
21. Niiro H, Otsuka T, Izuhara K, et al. Regulation by interleukin-10 and interleukin-4 of cyclooxygenase-2 expression in human neutrophils. Blood. 1997;89:1621-1628.
22. Fasano MB, Wells JD, McCall CE. Human neutrophils express the prostaglandin G/H synthase 2 gene when stimulated with bacterial lipopolysaccharide. Clin Immunol Immunopathol. 1998; 87:304-308.
23. Hamasaki Y, Matsumoto S, Kobayashi I, et al. Cyclosporin A inhibits leukotriene production in intact RBL-1 cells without inhibiting leukotriene biosynthetic enzymes. Prostaglandins Leukot Essent Fatty Acids. 1995;52:365-371.
24. Kukita A, Kukita T, Ouchida M, Maeda H, Yatsuki H, Kohashi O. Osteoclast-derived zinc finger (OCZF) protein with POZ domain, a possible transcriptional repressor, is involved in osteoclastogenesis. Blood. 1999;94:1987-1997.
25. Matsumoto K, Taki F, Miura M, Matsuzaki M. Serum levels of soluble IL-2R, IL-4 and soluble Fc epsilon RII in adult bronchial asthma. Chest. 1994;105:681-686.
26. Tang MLK, Coleman J, Kemp AS. Interleukin-4 and interferon-gamma production in atopic and non-atopic children with asthma. Clin Exp Allergy. 1995;25:515-521.
27. Kotsimbos TC, Ernst P, Hamid QA. Interleukin-13 and interleukin-4 are coexpressed in atopic asthma. Proc Assoc Am Physicians. 1996;108: 368-373.
28. Koning H, Neijens HJ, Baert MR, Oranje AP, Savelkoul HF. T cell subsets and cytokines in allergic and non-allergic children: analysis of IL-4, IFN-gamma and IL-13 mRNA expression and protein production. Cytokine. 1997;9:416-426.
29. Oliverstein R, Taha R, Minshall EM, Hamid QA. IL-4 and IL-5 mRNA expression in induced sputum of asthmatic subjects: comparison with bronchial wash. J Allergy Clin Immunol. 1999;103: 238-245.
30. De Vries JE, Gauchat JF, Aversa GG, Punnonen J, Gascan H, Yssel H. Regulation of IgE synthesis. Curr Opin Immunol. 1991;3:351-358.
31. Doucet C, Brouty-Boye D, Pottin-Clemenceau C, Jasmin C, Canonica GW, Azzarone B. IL-4 and IL-13 specifically increase adhesion molecule and inflammatory cytokine expression in human lung fibroblasts. Int Immunol. 1998;10:1421-1433.
32. Hilton DJ, Zhang JG, Metcalf D, Alexander WS, Nicola NA, Willson TA. Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc Natl Acad Sci U S A. 1996;93: 497-501.
33. Murata T, Taguchi J, Puri RK. Interleukin-13 receptor alpha' but not alpha chain: a functional component of interleukin-4 receptors. Blood. 1998;91:3884-3891.
34. Murata T, Obiri NI, Puri RK. Structure of and signal transduction through interleukin-4 and interleukin-13 receptors. Int J Mol Med. 1998;1:551-557.
35. Chomarat P, Banchereau J. Interleukin-4 and Interleukin-13: their similarities and discrepancies. Int Rev Immunol. 1998;17:1-52.
36. Van der Pouw Kraan TC, Van der Zee JS, Boeije LC, De Groot ER, Stapel SO, Aarden LA. The role of IL-13 in IgE synthesis by allergic asthma patients. Clin Exp Immunol. 1998;111:129-135.
37. Li L, Xia Y, Nguyen A, et al. Effect of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells. J Immunol. 1999;162:2477-2487.
38. Kroegel C, Julius P, Matthys H, Virchow JCJ, Luttmann W. Endobronchial secretion of interleukin-13 following local allergen challenge in atopic asthma: relationship to interleukin-4 and eosinophil counts. Eur Respir J. 1996;9:899-904.
39. Lenfant C, Khaltaev N. Global strategy for asthma management and prevention: NHLBI/ WHO workshop report. Bethesda, MD: NHLBI; 1995.
40. Djukanovic R, Roche WR, Wilson JW, Beasley C, Twentyman O, Holgate ST. Mucosal inflammation in asthma. Am Rev Respir Dis. 1990;142:434-457.
41. Bousquet J, Chanez P, Campbell AM, Vignola AM, Godard P. Cellular inflammation in asthma. Clin Exp Allergy. 1995;25(suppl 2):39-42.
42. Bousquet J, Chanez P, Lacoste Y, et al. Eosinophilic inflammation in asthma. N Engl J Med. 1990;323:1033-1039.
43. Walker C, Kaegi M, Braun P, Blaser K. Activated T cells and eosinophilia in bronchoalveolar lavage from subjects with asthma correlated with disease severity. J Allergy Clin Immunol. 1991;88: 935-942.
44. Beasley R, Burgess C, Crane J, Pearce N, Roche W. Pathology of asthma and its clinical implications. J Allergy Clin Immunol. 1993;92:148-154.
45. Till SJ, Durham SR, Rajakulasingam K, et al. Allergen-induced proliferation and interteukin-5 production by bronchoalveolar lavage and blood T cells after segmental allergen challenge. Am J Respir Crit Care Med. 1998;158:404-411.
46. Fahy JU, Kim KW, Liu J, Boushey HA. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J Allergy Clin Immunol. 1995;95:843-852.
47. Underwood S, Foster M, Raeburn D, Bottoms S, Karlsson JA. Time-course of antigen-induced airway inflammation in the guinea-pig and its relationship to airway hyperresponsiveness. Eur Respir J. 1995;8:2104-2113.
48. Sur S, Crotty TB, Kephart GM, et al. Suddenonset fatal asthma: a distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa? Am Rev Respir Dis. 1993; 148:713-719.
49. Lamblin C, Grosset P, Leblond IT, et al. Bronchial neutrophilia in patients with noninfectious status asthmaticus. Am J Respir Crit Care Med. 1998; 157:394-402.
50. Martin RJ, Cicutto LC, Smith HR, Ballard RD, Szefler SJ. Airways inflammation in nocturnal asthma. Am Rev Respir Dis. 1991;143:351-357.
51. O'Byrne PM, Dolovich J, Hargreave FE. Late asthmatic responses. Am Rev Respir Dis. 1987; 136:745-751.
52. Gaga M, FrewAJ, Varney V, Kay AB. Eosinophil activation and T lymphocyte infiltration in allergen-induced late phase reaction and classical delayed-type hypersensitivity. J Immunol. 1991; 147:816-822.
53. Barata LT, Ying S, Meng Q, et al. IL-4 and IL-5 positive T lymphocytes, eosinophils, and mast cells in allergen induced late-phase cutaneous reactions in atopic subjects. J Allergy Clin Immunol. 1998;101:223-230.
54. Diaz P, Gonzalez MC, Galleguillos FR, et al. Leukocytes and mediators in bronchoalveolar lavage during allergen-induced late phase asthmatic reactions. Am Rev Respir Dis. 1989;139:1383-1389.
55. Metzger WJ, Richerson HB, Worden K, Monick M, Hunninghake GW. Bronchoalveolar lavage of allergic asthmatic patients following allergen bronchoprovocation. Chest. 1986;89:477-483.
56. 4 and interieukin-8 levels in patients with asthma and allergic rhinitis-modulation by a lipid pathway inhibitor. Ann Allergy Asthma Immunol. 1998;81:331-336.
57. 4 release in stimulated asthmatic neutrophils by platelet activating factor. Thorax. 1997;52:1024-1029.
58. Sampson AP, Evans JM, Garland LG, Piper PJ, Costello JF. The generation and metabolism of leukotrienes in the ionophore-stimulated blood of normal and asthmatic subjects. Pulm Pharmacol. 1990;3:111-119.
59. 2 are involved in asthma attacks in children. J Asthma. 1998;35:445-448.
60. 2 translocates to membrane fraction in human neutrophils activated by stimuli that phospholylate mitogen-activated protein kinase. Proc Natl Acad Sci USA. 1994;91:3142-3146.
61. 2, 5-lipoxygenase, and 5-lipoxygenase-activating protein at the nuclear membrane of A23187-stimulated human neutrophils. Eur J Biochem. 1996; 238:250-258.
62. Brock TG, McNish RW, Peters-Golden P. Translocation and leukotriene synthetic capacity of nuclear 5-lipoxygenase in rat basophilic leukemia cells and alveolar macrophages. J Biol Chem. 1995;270:21652-21658.
63. Jakobsson PJ, Shaskin P, Larsson P, et al. Studles on the regulation and localization of 5-lipoxygenase in human B-lymphocytes. Eur J Biochem. 1995;232:37-46.
64. Pouliot M, McDonald PP, Borgeat P, McColl SR. Granulocyte/macrophage colony-stimulating factor stimulates the expression of the 5-lipoxygenase-activating protein (FLAP) in human neutrophils. J Exp Med. 1994;179:1225-1232.
65. 4 hydrolase in peripheral leukocytes of patients with atopic dermatitis. Arch Dermatol Res. 1996; 288:168-172.
66. 4 hydrolase gene. Eur J Biochem. 1995;231:65-71.
67. 4. J Biol Chem. 1984;259:11403-11407.
68. 4 biosynthesis by endogenous adenosine in ligand-activated human neutrophils. J Exp Med. 1997;186:1401-1406.